Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_700ff9a01db2075489cb7ed87392dc28 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-829 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
filingDate |
1998-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_daaf3d22e4cbf6e22e6a7a23f6aac934 |
publicationDate |
1998-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-H10306036-A |
titleOfInvention |
Administration of low-dose hemoglobin to increase perfusion |
abstract |
(57) Abstract: A pharmaceutical composition for treating hemorrhagic shock in a mammal is provided. SOLUTION: This is a sterile physiologically compatible solution having an intramolecularly crosslinked or intermolecularly crosslinked substrate-free hemoglobin concentration of 1 to 20%, and contains 30 mg of substrate-free hemoglobin / kg body weight due to hemorrhagic shock in mammals. The solution is administered at a dose of 121225 mg. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8889830-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018008729-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012117688-A1 |
priorityDate |
1992-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |